scholarly journals A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours

2013 ◽  
Vol 108 (5) ◽  
pp. 1061-1070 ◽  
Author(s):  
M A Warso ◽  
J M Richards ◽  
D Mehta ◽  
K Christov ◽  
C Schaeffer ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Solid Tumours ◽  
Peptide Inhibitor

scholarly journals Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker

2009 ◽  
Vol 101 (7) ◽  
pp. 1044-1050 ◽  
Author(s):  
P N Munster ◽  
D Marchion ◽  
S Thomas ◽  
M Egorin ◽  
S Minton ◽  
...  
Keyword(s):  
Phase I ◽  
Histone Deacetylase ◽  
Phase I Trial ◽  
Predictive Marker ◽  
Solid Tumours ◽  
Histone Deacetylase 2

Phase I trial of the sequential administration of pemetrexed (P) and docetaxel (D) in patients (pts) with advanced solid tumours

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 2108-2108 ◽  
Author(s):  
A. Lopez-Martin ◽  
R. Cubedo ◽  
I. Garcia-Rivas ◽  
D. Castellano ◽  
A. Perez-Romero ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Solid Tumours ◽  
Sequential Administration

scholarly journals Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumours

2012 ◽  
Vol 107 (8) ◽  
pp. 1277-1285 ◽  
Author(s):  
M F Kozloff ◽  
L P Martin ◽  
M Krzakowski ◽  
T A Samuel ◽  
T A Rado ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase I Trial ◽  
Small Cell ◽  
Solid Tumours ◽  
Small Cell Lung

A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours

2004 ◽  
Vol 40 (14) ◽  
pp. 2047-2052 ◽  
Author(s):  
Ulrich Keilholz ◽  
Ronny Schuster ◽  
Alexander Schmittel ◽  
Nikolaos Bechrakis ◽  
Jan Siehl ◽  
...  
Keyword(s):  
Phase I ◽  
Uveal Melanoma ◽  
Phase I Trial ◽  
Solid Tumours ◽  
Clinical Phase

Phase I trial of Irinotecan (CPT-11)I in childhood solid tumours

1997 ◽  
Vol 33 ◽  
pp. S249
Author(s):  
F. Pein ◽  
F. Doz ◽  
D. Frappaz ◽  
E. Lucchi ◽  
S. Moretti ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Solid Tumours

scholarly journals First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours

2012 ◽  
Vol 106 (8) ◽  
pp. 1379-1385 ◽  
Author(s):  
T A Yap ◽  
H Cortes-Funes ◽  
H Shaw ◽  
R Rodriguez ◽  
D Olmos ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Solid Tumours ◽  
The Novel

scholarly journals Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas

2011 ◽  
Vol 47 (7) ◽  
pp. 997-1005 ◽  
Author(s):  
Shivaani Kummar ◽  
Martin E. Gutierrez ◽  
Alice Chen ◽  
Ismail B. Turkbey ◽  
Deborah Allen ◽  
...  
Keyword(s):  
Signal Transduction ◽  
Phase I ◽  
Phase I Trial ◽  
Solid Tumours ◽  
Signal Transduction Pathways

A phase I trial of LY2584702 tosylate, a p70 S6 kinase inhibitor, in patients with advanced solid tumours

2014 ◽  
Vol 50 (5) ◽  
pp. 867-875 ◽  
Author(s):  
Anthony Tolcher ◽  
Jonathan Goldman ◽  
Amita Patnaik ◽  
Kyriakos P. Papadopoulos ◽  
Paul Westwood ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Kinase Inhibitor ◽  
Solid Tumours ◽  
S6 Kinase ◽  
P70 S6 Kinase

scholarly journals Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial

2009 ◽  
Vol 101 (8) ◽  
pp. 1241-1247 ◽  
Author(s):  
D Arnold ◽  
W Voigt ◽  
P Kiewe ◽  
C Behrmann ◽  
S Lindemann ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Solid Tumours ◽  
Weekly Administration
Sign in / Sign up

Export Citation Format

Share Document